Global Computational Biological Market Size By Service, By Application, By End-User, By Geographic Scope And Forecasts

Computational Biological Market Size and Forecast

Computational Biological Market size was valued at USD 8.39 Billion in 2024 and is projected to reach USD 33.11 Billion by 2031, growing at a CAGR of 20.64% from 2024 to 2031.

Computational biology uses computational methods and algorithms to analyze and model biological systems and processes. This interdisciplinary field uses biology, computer science, mathematics, and statistics to understand complicated biological data, allowing researchers to learn about molecular mechanisms, gene expression, protein interactions, and cellular functions.

Computational biology has many diverse and important applications. They include drug discovery, which uses computational models to identify possible therapeutic candidates; genomics, which involves sequencing and analyzing genomes to better understand genetic variants; and systems biology, which simulates intricate interactions within biological networks.

Furthermore, computational biology is important in personalized medicine since it analyzes genomic data to adapt therapies to people and evolutionary studies that identify genetic links between species.

Global Computational Biological Market Dynamics

The key market dynamics that are shaping the Computational Biological Market include:

Key Market Drivers

Increasing Prevalence of Chronic Diseases and Genetic Disorders: The increasing prevalence of genetic illnesses is generating demand for computational biology technologies that can evaluate genomic data and produce individualized treatments. According to the World Health Organization (WHO), the global prevalence of diabetes among individuals over 18 years old increased from 4.7% in 1980 to 8.5% in 2014. Also, the National Cancer Institute reports that 39.5% of men and women will be diagnosed with cancer at some point in their lives, based on statistics from 2015-2017.

Advancements in Big Data Analytics and Artificial Intelligence: The rapid advancement of data processing capabilities and AI algorithms is driving growth in computational biology. The National Institutes of Health (NIH) reports that the cost of sequencing a human genome has reduced from around USD 100 Million in 2001 to less than $1,000 in 2020, making genetic data more accessible. Furthermore, according to the International Data Corporation (IDC), the global big data and business analytics market is anticipated to increase from USD 189.1 Billion in 2019 to USD 274.3 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 13.2%.

Increasing Government Funding and Initiatives: Government funding of genomics and computational biology research is propelling market expansion. For example, the Human Genome Research Institute budget at the U.S. National Institutes of Health (NIH) jumped from USD 518 Million in 2015 to USD 604 Million in 2020. Similarly, the European Commission's Horizon 2020 program provided €77 billion for research and innovation between 2014 and 2020, with a large amount going toward health and biotechnology research.

Key Challenges:

High Initial Cost and Maintenance Costs: Implementing computational biology solutions necessitates substantial initial investments in hardware, software, and infrastructure. Furthermore, the continuous maintenance and upgrading expenses are significant, especially for smaller enterprises and academic institutions with limited resources. This financial barrier impedes the adoption of computational biology techniques and restricts market growth.

Lack of Trained Professionals: The Computational Biological Market is limited by a lack of skilled people who can successfully use computational tools and methodologies to interpret complicated biological data. To overcome the skill gap and support market growth, multidisciplinary training programs combining knowledge in biology, computer science, mathematics, and statistics are required.

Key Trends:

Integration of Artificial Intelligence and Machine Learning: The Computational Biological Market is rapidly adopting artificial intelligence (AI) and machine learning (ML) technology to improve data analysis and predictive modeling capabilities. These innovations enable more effective processing of massive biological information, resulting in substantial advances in drug discovery and customized treatment. The combination of AI and ML is predicted to streamline processes and increase the accuracy of biological predictions, hence driving market growth.

Rise in Personalized Medicine: Personalized medicine is a developing trend that tailors medical treatment to individual features, requirements, and choices. This trend is being driven by advances in genetics and bioinformatics, which enable more precise disease modeling and therapeutic development. As the desire for tailored treatment choices develops, computational biology plays a significant role in assessing genetic data and predicting patient reactions, thus improving therapeutic efficacy and safety.

Expansion of Bioinformatics in Research: Bioinformatics applications are growing in the Computational Biological Market across a variety of research fields, including genomics, proteomics, and pharmacogenomics. This trend is fueled by the growing number of biological data created by sequencing initiatives and clinical trials. Enhanced bioinformatics tools are critical for understanding this data, allowing the discovery of new biomarkers and therapeutic targets, and ultimately assisting in the development of novel medical treatments.

Global Computational Biological Market Regional Analysis

Here is a more detailed regional analysis of the Computational Biological Market:

North America:

According to Verified Market Research, North America is estimated to dominate the market during the forecast period. North America, especially the United States, is home to a well-established network of academic institutes and biotechnology firms that drive computational biology innovation. According to the National Science Foundation (NSF), the United States spent USD 667 Billion on research and development in 2019, with 17% of that going toward biological sciences. The National Institutes of Health (NIH) alone invested USD 41.7 Billion in biomedical research in 2020, with a large amount going toward computational biology initiatives.

Furthermore, the rising prevalence of chronic diseases in North America is boosting the need for computational biology methods to create targeted therapies. According to the Centers for Disease Control and Prevention (CDC), 6 in 10 persons in the United States have at least one chronic disease, with 4 in 10 having two or more. The American Cancer Society forecasts that 1.9 million new cancer cases will be diagnosed in the United States in 2021, increasing the demand for computational approaches in oncology research and treatment.

Asia Pacific:

The Asia Pacific region is estimated to exhibit the highest growth within the market during the forecast period. The Asia Pacific region is experiencing an increasing burden of chronic diseases, demanding improved computational approaches to research and treatment. According to the World Health Organization (WHO), noncommunicable illnesses cause 71% of all deaths worldwide, with the Western Pacific region (which includes much of Asia) accounting for 12.4 million fatalities per year. The International Diabetes Federation estimates that the number of diabetics in Southeast Asia will increase by 74%, from 88 million in 2019 to 153 million by 2045, highlighting the critical need for computational biology solutions in disease management and drug discovery.

Furthermore, governments in the Asia Pacific are significantly boosting their funding in biotechnology and computational research. India's Department of Biotechnology allotted ₹2,581 crore (about USD 350 Million) for the fiscal year 2021-2022, up 14.4% from the previous year. In 2019, Japan's Cabinet Office reported investments of ¥323.7 billion (about USD 3 Billion) in the life sciences and biotechnology sectors. These investments are strengthening the region's computational biology skills and propelling the market forward.

Computational Biological Market: Segmentation Analysis

The Global Computational Biological Market is segmented based on Service, Application, End-User, and Geography.

Computational Biological Market, By Service

• Databases
• Infrastructure & Hardware
• Software

Based on Service, the Computational Biological Market is segmented into Databases, Infrastructure & Hardware, and Software. The software segment is estimated to dominate the Computational Biological Market during the forecast period due to the vital role software plays in data processing, bioinformatics, and modeling, all of which are required for a variety of applications like genomics and drug discovery. The growing volume of biological data generated by research programs fuels the demand for innovative software solutions that enable effective data administration and interpretation, cementing the segment's market leadership.

Computational Biological Market, By Application

• Preclinical Drug Development
• Human Body Simulation Software
• Drug Discovery & Disease Modelling
• Cellular & Biological Simulation
• Others

Based on Application, the Computational Biological Market is segmented into Preclinical Drug Development, Human Body Simulation Software, Drug Discovery & Disease Modelling, Cellular & Biological Simulation, and Others. The drug discovery & disease modeling segment is estimated to hold the majority share in the forecast period in the Computational Biological Market due to the growing desire for novel treatment solutions and effective drug development methods. Pharmaceutical companies are experiencing high attrition rates in drug development, making computational biology techniques that aid in drug discovery and disease modeling increasingly important. These techniques allow researchers to evaluate large datasets and forecast therapeutic efficacy, significantly shortening the time-to-market for new medicines.

Computational Biological Market, By End-User

• Industrial
• Commercial
• Academics

Based on End-User, the Computational Biological Market is segmented into Industrial, Commercial, and Academics. The industrial segment is estimated to dominate the market during the forecasted period due to these companies' considerable investments in R&D, especially in medication discovery and development processes. They use computational biology techniques to assess complicated biological data, improve workflows, and speed up the development of novel medicines. As a result, their reliance on computational biology continues to drive significant market demand, solidifying its leadership position.

Computational Biological Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Computational Biological Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North American region is estimated to hold the largest share of the Computational Biological Market owing to strong investments in R&D, particularly in the disciplines of pharmacogenomics and drug discovery. The region benefits from strong infrastructure, a significant concentration of biotechnology companies, and government measures that encourage innovation. This dominance is projected to continue as North America continues to lead the way in computational biology technologies and applications, supporting market expansion and collaboration.

Key Players

• The "Computational Biological Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Accelrys, Chemical Computing Group, Inc., Entelos, In-silico Biotechnology AG, Nimbus Discovery LLC, Rhenovia Pharma SAS, Certara, Compugen Ltd, Generate AG, and Leadscope, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.